Japan · Delayed Price · Currency is JPY Healios K.K. Statistics
Total Valuation
Healios K.K. has a market cap or net worth of JPY 42.80 billion. The enterprise value is 34.55 billion.
| Market Cap | 42.80B |
| Enterprise Value | 34.55B |
Important Dates
The last earnings date was Thursday, May 14, 2026.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Healios K.K. has 135.00 million shares outstanding. The number of shares has increased by 25.72% in one year.
| Current Share Class | 135.00M |
| Shares Outstanding | 135.00M |
| Shares Change (YoY) | +25.72% |
| Shares Change (QoQ) | -15.23% |
| Owned by Insiders (%) | 21.47% |
| Owned by Institutions (%) | 1.27% |
| Float | 69.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 578.32 |
| PB Ratio | 5.65 |
| P/TBV Ratio | 13.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.03 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -8.94 |
Financial Position
The company has a current ratio of 2.05, with a Debt / Equity ratio of 0.34.
| Current Ratio | 2.05 |
| Quick Ratio | 1.95 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.67 |
| Interest Coverage | -6.10 |
Financial Efficiency
Return on equity (ROE) is -65.40% and return on invested capital (ROIC) is -31.48%.
| Return on Equity (ROE) | -65.40% |
| Return on Assets (ROA) | -11.87% |
| Return on Invested Capital (ROIC) | -31.48% |
| Return on Capital Employed (ROCE) | -21.02% |
| Weighted Average Cost of Capital (WACC) | 12.26% |
| Revenue Per Employee | 986,667 |
| Profits Per Employee | -41.77M |
| Employee Count | 75 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Healios K.K. has paid 111.00 million in taxes.
| Income Tax | 111.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.62% in the last 52 weeks. The beta is 1.39, so Healios K.K.'s price volatility has been higher than the market average.
| Beta (5Y) | 1.39 |
| 52-Week Price Change | -42.62% |
| 50-Day Moving Average | 353.50 |
| 200-Day Moving Average | 422.24 |
| Relative Strength Index (RSI) | 37.73 |
| Average Volume (20 Days) | 1,521,030 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Healios K.K. had revenue of JPY 74.00 million and -3.13 billion in losses. Loss per share was -34.73.
| Revenue | 74.00M |
| Gross Profit | -115.00M |
| Operating Income | -3.72B |
| Pretax Income | -3.01B |
| Net Income | -3.13B |
| EBITDA | -3.44B |
| EBIT | -3.72B |
| Loss Per Share | -34.73 |
Balance Sheet
The company has 10.87 billion in cash and 2.59 billion in debt, with a net cash position of 8.28 billion or 61.33 per share.
| Cash & Cash Equivalents | 10.87B |
| Total Debt | 2.59B |
| Net Cash | 8.28B |
| Net Cash Per Share | 61.33 |
| Equity (Book Value) | 7.58B |
| Book Value Per Share | 60.00 |
| Working Capital | 6.05B |
Cash Flow
In the last 12 months, operating cash flow was -3.67 billion and capital expenditures -192.00 million, giving a free cash flow of -3.87 billion.
| Operating Cash Flow | -3.67B |
| Capital Expenditures | -192.00M |
| Depreciation & Amortization | 277.00M |
| Net Borrowing | n/a |
| Free Cash Flow | -3.87B |
| FCF Per Share | -28.63 |
Margins
| Gross Margin | -155.41% |
| Operating Margin | -5,027.03% |
| Pretax Margin | -4,070.27% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Healios K.K. does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -25.72% |
| Shareholder Yield | -25.72% |
| Earnings Yield | -7.32% |
| FCF Yield | -9.03% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for Healios K.K. is 776.50, which is 149.68% higher than the current price. The consensus rating is "Buy".
| Price Target | 776.50 |
| Price Target Difference | 149.68% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 486.26% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Healios K.K. has an Altman Z-Score of 1.48 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.48 |
| Piotroski F-Score | 2 |